Gain 6 to 9 Weeks by Conducting Trials in Canada
Taking full advantage of Canada's favorable regulatory landscape, Altasciences’ clinical facility in Montréal continues to be a popular choice, successfully completing hundreds of clinical trials each year.
In this issue of The Altascientist, we discuss the distinct benefits of conducting early phase clinical research on novel compounds in Canada versus other countries.
We cover:
• Canadian CTA trials–time and cost savings
• regulatory review process predictability
• business efficiency cost savings
• clinical trial participants
• Canadian CTA frequently asked questions
You may also be interested in the following resources:
Webpage: Altasciences' Three Clinical Trial Facilities
Videos:
- Accelerate Your Data With Altasciences’ Co-located Clinic and Lab
- Canada’s Regulatory Requirements for CTA Filings
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programmes, to offer an integrated/synchronised approach to CRO and CDMO services.
VIRTUAL TOUR: Discover our In-House R&D and Formulation Laboratories
Enhance Your Outcomes With Our Analytical Services
Altasciences’ in-house R&D and formulation laboratories offer an extensive array of analytical solutions to support sponsors’ drug development and manufacturing programs.
Our services include:
• HPLC/UPLC testing
• Method development and validation
• ICH stability storage and testing
• APIs, excipients, and packaging components
• Drug product release testing, including controlled substances
Take a virtual tour of our laboratories, or consult with one of our experts to discuss your study needs.
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Safety Assessment for Ophthalmic Products
Explore Our Nonclinical Research Facilities
Altasciences’ North American Nonclinical Research Facilities
Our nonclinical research facilities include 585,000 square feet of purpose-built space in four strategically placed locations throughout North America. We provide comprehensive regulatory safety testing, bioanalysis, and other research support services for rodent and non-rodent species. Altasciences conducts over 700 safety studies annually, offering a full range of in vivo GLP and non-GLP safety assessments. Our solutions include pivotal toxicology, safety pharmacology, and laboratory services that meet global regulatory requirements for small and large molecules to support your IND, CTA, NDA, or BLA submissions.
Learn more about our specific capabilities at each of our facilities or consult with one of our experts to discuss your study needs.
EXPLORE OUR FACILITIES
Have five minutes? Discover our extensive site capabilities:
• Webpage: Full Range of Preclinical Drug Development Solutions
• Fact Sheet: Preclinical Services Capabilities
• The Altascientist: Planning Your Preclinical Assessment
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Insights―Successful Manufacturing of Clinical Trial Supply
Discover the Secrets to Clinical Trial Success
As an integrated CRO/CDMO, Altasciences’ Clinical and CDMO teams work in tandem to manufacture the optimal dosage in preparation for first-in-human clinical trials.
In this latest podcast, our formulation and pharmacy experts share their secrets for successfully completing clinical trials and resolving issues that could impact your drug development program’s timeline.
Speak with our experts for all your pharmaceutical development and manufacturing needs in support of your upcoming clinical trials.
Related resources that may interest you:
• Webpage: Altasciences’ Manufacturing and Analytical Services
• Scientific Journal: Maximizing Formulations for First-in-Human Trials
• Infographic: Benefits of Using Liquid-Filled Capsules in Clinical Trials
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Cancer Treatments, Clinical Trials, and the Motivation to Innovate
Getting to the Heart of Science with Michelle Newby
At the heart of science are stories—stories of courage, challenges, successes, lessons, and people. These stories motivate us in the pursuit of knowledge and breathe life into the work we do as researchers. They remind us of the immense benefits of drug development.
Don’t Delay Your Study Due to NHP Supply
Altasciences Ensures Nonhuman Primate Availability
Several preclinical CROs are expecting an impact on study start dates due to nonhuman primate (NHP) supply constraints. NOT Altasciences. We ensure NHP availability! We have the capacity at our four preclinical sites to start your studies six to eight weeks following contracting, thanks to our steady supply of NHPs.
SCHEDULE YOUR NHP STUDIES TODAY
At Altasciences, we remove the stress of sourcing research animals so that you can start your studies when you need to, with:
- Dedicated and diversified cynomolgus monkey supply agreements in place to allow for faster start-up timelines;
- A continuously maintained and backfilled population of hundreds of naïve NHPs at our preclinical facilities.
You can schedule newly contracted NHP studies to start immediately.
Have five minutes? Discover our extensive site capabilities:
- Webpage: Full Range of Preclinical Drug Development Solutions
- Fact Sheet: Preclinical Services Capabilities
- The Altascientist: Planning Your Preclinical Assessment
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Design and Validation of a Bioanalytical Method to Support a Clinical Pharmacokinetic Study Involving the Use of Multiple Lots of the Biological Therapeutic Drug
Clinical Trials Arena: CRO Altasciences Works With Alzamend for Phase IIa Trial in Alzheimer's
Custom Dosage Form Solutions for All Study Phases
Versatile Dosage Forms―From Formulation to Market
For decades now, our U.S.-based cGMP manufacturing and analytical testing facility has been moving molecules from benchtop to market. Following formulation, we manufacture the dosage form you require for your nonclinical and clinical studies, as well as your commercial batches.
Dosage forms we manufacture and package include tablets, liquid-filled hard-shell capsules, powder-filled capsules, over-encapsulation, injectables, liquids and suspensions, creams, and gels.
Consult with our experts to discover how we can fulfill your manufacturing needs.
Resources that may interest you:
• Infographic: Benefits of Liquid-Filled Capsules as a Dosage Form
• Quick Chat: What Our Facility Expansions Mean For You
• Webpage: Altasciences’ Comprehensive Drug Manufacturing and Analytical Testing Services